Alan Dove says he thinks patients are "true believers" in XMRV because of seeking ridicule from outsiders in order to be a martyr in the eyes of other believers. I thought it took a Sharpe to make this stuff up. Please correct him as kindly as you can.
url removed
My comments (awaiting moderation)
url removed
My comments (awaiting moderation)
I think youre overreacting. Most of the ME/CFS community is saying they dont know what to think about murine leukemia viruses, which is, incidentally, the same think Ian Lipkin says. Yes, I know, contamination. But that really cant explain, for instance, negative controls when they were handled the same way as the samples (which I think is the case). No contamination has been demonstrated, which is something which directly applies to the Lombardi study. There could be some sort of as-yet-undetermined contamination which could explain things.
But its normal for science to have false leads this early in the process. Maybe the MLVs are a false lead, and maybe the thought that *all* results are explainable by contamination is a false lead. Its too soon to tell. As Lipkin says, sometimes other (good!) scientists are unable to replicate a particular result and WPI deserves a chance to replicate their own methods in a blinded study. Any conclusion prior to that is premature.
Maybe MLVs will turn out to be unimportant. Maybe methods will turn out to be more important than virologists are accustomed to thinking. At this point, I agree with Lipkins public statment, that we have a state of confusion.
The really important point here, the take-home message, is that ME/CFS patients have been basically thrown in a dungeon for the last few decades. Did you know that the federal research budget for ME/CFS is generally only $4-6 million? Compare to MS, $144 million, Asthma, $300 million, Alzheimers, $500 million. Whether or not any retrovirus is involved, the important thing is that ME/CFS patients deserve hard science, not insults. If you dont want them believing in XMRV, then, by all means, get NIH to give some funding for something else. Despite the lack of funding, there is no lack of promising avenues. For instance:
Jammes Y, Steinberg JG, Delliaux S, Brgeon F. Chronic fatigue syndrome combines increased exercise-induced oxidative stress and reduced cytokine and Hsp responses. J Intern Med. 2009 Aug;266(2):196-206. Epub 2009 May 19. PMID: 19457057
Chia J, Chia A, Voeller M, Lee T, Chang R. Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J Clin Pathol. 2010 Feb;63(2):165-8. Epub 2009 Oct 14. PMID: 19828908
Fletcher MA, Zeng XR, Maher K, Levis S, Hurwitz B, Antoni M, Broderick G, Klimas NG. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS One. 2010 May 25;5(5):e10817. PMID: 20520837
Kerr JR, Gough J, Richards SC, Main J, Enlander D, McCreary M, Komaroff AL, Chia JK. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Gen Virol. 2010 Apr;91(Pt 4):893-7. Epub 2009 Dec 9. PMID: 20007355
Zhang L, Gough J, Christmas D, Mattey DL, Richards SC, Main J, Enlander D, Honeybourne D, Ayres JG, Nutt DJ, Kerr JR. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol. 2010 Feb;63(2):156-64. Epub 2009 Dec 2. PMID: 19955554
Peckerman A, LaManca JJ, Dahl KA, Chemitiganti R, Qureishi B, Natelson BH. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am J Med Sci. 2003 Aug;326(2):55-60. PMID: 12920435
Konstantinov K, von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest. 1996 Oct 15;98(8):1888-96. PMID: 8878441
Whistler T, Jones JF, Unger ER, Vernon SD. Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol. 2005 Mar 24;5(1):5. PMID: 15790422
Let me correct myself slightly. The ME/CFS community has all types, including many who have largely abandoned, and some who never believed, the XMRV/MLV theory in the first place. Many others (and I think these mentioned groups comprise the great majority) are taking a cautious but wait-and-see attitude, but concerned that the scientific process may be cut shortregardless of what the outcome is on MLVs, we want to know for sure what it is. We care less what is wrong than that someone looks dilligently and finds appropriate treatment as soon as possible.